Berger Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.23M | Buy |
6,712
+169
| +3% | +$132K | 0.34% | 77 |
|
2025
Q1 | $5.4M | Sell |
6,543
-1
| -0% | -$826 | 0.38% | 68 |
|
2024
Q4 | $5.05M | Buy |
6,544
+803
| +14% | +$620K | 0.35% | 73 |
|
2024
Q3 | $5.09M | Buy |
5,741
+2,841
| +98% | +$2.52M | 0.37% | 72 |
|
2024
Q2 | $2.63M | Buy |
2,900
+44
| +2% | +$39.8K | 0.21% | 100 |
|
2024
Q1 | $2.22M | Buy |
2,856
+104
| +4% | +$80.9K | 0.18% | 113 |
|
2023
Q4 | $1.6M | Sell |
2,752
-37
| -1% | -$21.6K | 0.17% | 105 |
|
2023
Q3 | $1.5M | Buy |
2,789
+14
| +0.5% | +$7.52K | 0.17% | 105 |
|
2023
Q2 | $1.3M | Sell |
2,775
-82
| -3% | -$38.5K | 0.15% | 107 |
|
2023
Q1 | $981K | Buy |
2,857
+453
| +19% | +$156K | 0.12% | 109 |
|
2022
Q4 | $880K | Buy |
2,404
+371
| +18% | +$136K | 0.12% | 110 |
|
2022
Q3 | $657K | Buy |
2,033
+594
| +41% | +$192K | 0.1% | 123 |
|
2022
Q2 | $467K | Buy |
1,439
+40
| +3% | +$13K | 0.07% | 146 |
|
2022
Q1 | $401K | Sell |
1,399
-159
| -10% | -$45.6K | 0.05% | 169 |
|
2021
Q4 | $430K | Buy |
1,558
+153
| +11% | +$42.2K | 0.06% | 165 |
|
2021
Q3 | $325K | Buy |
1,405
+195
| +16% | +$45.1K | 0.06% | 152 |
|
2021
Q2 | $278K | Sell |
1,210
-214
| -15% | -$49.2K | 0.05% | 164 |
|
2021
Q1 | $266K | Buy |
1,424
+62
| +5% | +$11.6K | 0.06% | 157 |
|
2020
Q4 | $230K | Buy |
+1,362
| New | +$230K | 0.04% | 187 |
|